Found: 2
Select item for more details and to access through your institution.
BTK inhibitors synergise with 5‐FU to treat drug‐resistant TP53‐null colon cancers.
- Published in:
- Journal of Pathology, 2020, v. 250, n. 2, p. 134, doi. 10.1002/path.5347
- By:
- Publication type:
- Article
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0100947
- By:
- Publication type:
- Article